Adicet Bio, Inc. (ACET) › Operating Cash FlowAdicet Bio, Inc. (ACET) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2017: -$10.98M2018: -$18.18M2019: -$27.88M2020: -$41.55M2021: -$51.05M2022: -$44.77M2023: -$93.72M2024: -$92.38M2025: -$95.25M-$95.25M2017Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$95.25M-3.1%2024-$92.38M+1.4%2023-$93.72M-109.4%2022-$44.77M+12.3%2021-$51.05M-22.9%2020-$41.55M-49.0%2019-$27.88M-53.4%2018-$18.18M-65.5%2017-$10.98M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share